YBX1 and hepatocellular carcinoma: Exosomal circRNA-SORE stabilized YBX1 in the cytoplasm, thus preventing YBX1 from subsequently be degraded by the E3 ligase PRP19 in the nucleus and enhancing the sorafenib resistance of HCC 22.